Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf4g
|
ENSMUSG00000017688.8 | hepatocyte nuclear factor 4, gamma |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_3507630_3507781 | Hnf4g | 325 | 0.915258 | -0.81 | 4.9e-02 | Click! |
chr3_3508156_3508334 | Hnf4g | 215 | 0.951929 | -0.60 | 2.1e-01 | Click! |
chr3_3507908_3508064 | Hnf4g | 44 | 0.982222 | 0.24 | 6.5e-01 | Click! |
chr3_3502715_3502870 | Hnf4g | 5238 | 0.263596 | -0.17 | 7.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_118232810_118233328 | 14.57 |
Gm17399 |
predicted gene, 17399 |
82838 |
0.08 |
chr8_93959067_93959388 | 8.92 |
Gnao1 |
guanine nucleotide binding protein, alpha O |
3617 |
0.19 |
chr2_163037922_163038123 | 8.76 |
Ift52 |
intraflagellar transport 52 |
15579 |
0.11 |
chr2_163038300_163038466 | 7.88 |
Ift52 |
intraflagellar transport 52 |
15940 |
0.11 |
chr2_163038133_163038284 | 7.25 |
Ift52 |
intraflagellar transport 52 |
15765 |
0.11 |
chr9_7857852_7858186 | 6.21 |
Birc3 |
baculoviral IAP repeat-containing 3 |
2307 |
0.27 |
chr11_52257389_52257568 | 6.20 |
Tcf7 |
transcription factor 7, T cell specific |
17399 |
0.11 |
chr1_87197456_87197613 | 6.14 |
Chrnd |
cholinergic receptor, nicotinic, delta polypeptide |
6690 |
0.1 |
chr8_115831765_115832080 | 6.12 |
Maf |
avian musculoaponeurotic fibrosarcoma oncogene homolog |
124128 |
0.06 |
chr5_139358617_139359046 | 6.08 |
Cyp2w1 |
cytochrome P450, family 2, subfamily w, polypeptide 1 |
4255 |
0.13 |
chr10_78722102_78722266 | 6.07 |
Casp14 |
caspase 14 |
3890 |
0.13 |
chr8_93958816_93959000 | 5.96 |
Gnao1 |
guanine nucleotide binding protein, alpha O |
3936 |
0.18 |
chr2_163037706_163037864 | 5.91 |
Ift52 |
intraflagellar transport 52 |
15342 |
0.11 |
chr7_143599041_143599206 | 5.50 |
Cars |
cysteinyl-tRNA synthetase |
558 |
0.5 |
chr14_18221191_18221360 | 5.48 |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
8903 |
0.14 |
chr6_91111481_91112156 | 5.28 |
Nup210 |
nucleoporin 210 |
4978 |
0.17 |
chr7_122119170_122119504 | 5.18 |
Palb2 |
partner and localizer of BRCA2 |
5108 |
0.1 |
chr6_94317117_94317268 | 5.16 |
Gm44307 |
predicted gene, 44307 |
6842 |
0.22 |
chr8_84130948_84131146 | 4.99 |
Podnl1 |
podocan-like 1 |
3229 |
0.09 |
chr7_16203156_16203319 | 4.93 |
Dhx34 |
DEAH (Asp-Glu-Ala-His) box polypeptide 34 |
964 |
0.4 |
chr9_26923072_26923237 | 4.79 |
Gm1110 |
predicted gene 1110 |
43 |
0.97 |
chr6_121048029_121048203 | 4.71 |
Gm4651 |
predicted gene 4651 |
16348 |
0.15 |
chr2_163038512_163038663 | 4.71 |
Mybl2 |
myeloblastosis oncogene-like 2 |
16100 |
0.11 |
chr5_25054101_25054285 | 4.62 |
Prkag2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
46449 |
0.11 |
chr14_8183658_8183827 | 4.62 |
Pdhb |
pyruvate dehydrogenase (lipoamide) beta |
10717 |
0.18 |
chr1_89968656_89968807 | 4.52 |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
27721 |
0.16 |
chr9_108085374_108085555 | 4.51 |
Apeh |
acylpeptide hydrolase |
564 |
0.42 |
chr4_41596919_41597300 | 4.49 |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
27334 |
0.09 |
chr18_61368151_61368467 | 4.47 |
Gm25301 |
predicted gene, 25301 |
29504 |
0.12 |
chr3_146443474_146443641 | 4.42 |
Ctbs |
chitobiase |
6238 |
0.14 |
chr7_145087928_145088130 | 4.37 |
Gm45181 |
predicted gene 45181 |
74967 |
0.09 |
chr11_95709774_95709938 | 4.34 |
Zfp652 |
zinc finger protein 652 |
2817 |
0.17 |
chr11_107688566_107688742 | 4.33 |
Helz |
helicase with zinc finger domain |
15694 |
0.16 |
chr14_63213401_63213577 | 4.31 |
Gata4 |
GATA binding protein 4 |
118 |
0.96 |
chr5_112958387_112958546 | 4.30 |
Grk3 |
G protein-coupled receptor kinase 3 |
32668 |
0.15 |
chr12_3860173_3860352 | 4.22 |
Dnmt3a |
DNA methyltransferase 3A |
759 |
0.58 |
chr7_68724802_68724989 | 4.21 |
Gm44692 |
predicted gene 44692 |
1572 |
0.44 |
chr17_46438387_46438728 | 4.19 |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
100 |
0.92 |
chr6_145811271_145811882 | 4.14 |
Rassf8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
3193 |
0.26 |
chr7_145043507_145043672 | 4.10 |
Ccnd1 |
cyclin D1 |
103664 |
0.05 |
chr17_48547820_48547990 | 4.10 |
Gm49896 |
predicted gene, 49896 |
8828 |
0.21 |
chr8_72493722_72493899 | 4.09 |
Gm17435 |
predicted gene, 17435 |
866 |
0.32 |
chr15_77077850_77078204 | 4.08 |
1700109K24Rik |
RIKEN cDNA 1700109K24 gene |
6371 |
0.11 |
chr8_112018421_112018578 | 4.05 |
Gm6793 |
predicted gene 6793 |
3491 |
0.17 |
chr7_4651233_4651574 | 4.03 |
Ppp6r1 |
protein phosphatase 6, regulatory subunit 1 |
3998 |
0.09 |
chr4_62508801_62509208 | 4.01 |
Hdhd3 |
haloacid dehalogenase-like hydrolase domain containing 3 |
5537 |
0.12 |
chr11_106154879_106155044 | 4.00 |
Map3k3 |
mitogen-activated protein kinase kinase kinase 3 |
2897 |
0.13 |
chr18_12882054_12882208 | 3.96 |
Osbpl1a |
oxysterol binding protein-like 1A |
2154 |
0.28 |
chr16_22141025_22141191 | 3.88 |
Igf2bp2 |
insulin-like growth factor 2 mRNA binding protein 2 |
3899 |
0.23 |
chr7_138853576_138853872 | 3.87 |
Ppp2r2d |
protein phosphatase 2, regulatory subunit B, delta |
6864 |
0.14 |
chr4_46867682_46867844 | 3.85 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
7861 |
0.27 |
chr2_128174660_128174970 | 3.85 |
Gm14009 |
predicted gene 14009 |
15172 |
0.2 |
chr2_157550429_157550705 | 3.84 |
Gm14286 |
predicted gene 14286 |
5098 |
0.12 |
chr8_115833522_115833689 | 3.84 |
Maf |
avian musculoaponeurotic fibrosarcoma oncogene homolog |
125811 |
0.05 |
chr10_61337527_61337708 | 3.84 |
Pald1 |
phosphatase domain containing, paladin 1 |
4710 |
0.15 |
chr8_46385009_46385281 | 3.82 |
Gm45253 |
predicted gene 45253 |
743 |
0.6 |
chr5_143137674_143137845 | 3.79 |
Olfr718-ps1 |
olfactory receptor 718, pseudogene 1 |
441 |
0.7 |
chr1_60824712_60825126 | 3.74 |
Gm11581 |
predicted gene 11581 |
15803 |
0.12 |
chr6_121890040_121890777 | 3.73 |
Mug1 |
murinoglobulin 1 |
4831 |
0.21 |
chr3_69139928_69140109 | 3.73 |
Gm1647 |
predicted gene 1647 |
8785 |
0.14 |
chr2_128512792_128512943 | 3.73 |
Morrbid |
myeloid RNA regulator of BCL2L11 induced cell death |
10102 |
0.17 |
chr5_63897626_63897962 | 3.73 |
0610040J01Rik |
RIKEN cDNA 0610040J01 gene |
20318 |
0.15 |
chr2_181091052_181091203 | 3.67 |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
4294 |
0.17 |
chr15_95767994_95768168 | 3.64 |
Gm8849 |
predicted gene 8849 |
7673 |
0.12 |
chr1_13103635_13103786 | 3.63 |
Prdm14 |
PR domain containing 14 |
23453 |
0.13 |
chr2_165284491_165284712 | 3.61 |
Slc35c2 |
solute carrier family 35, member C2 |
1001 |
0.46 |
chr16_31419378_31420071 | 3.59 |
Bdh1 |
3-hydroxybutyrate dehydrogenase, type 1 |
2556 |
0.19 |
chr19_46484470_46484829 | 3.58 |
Sufu |
SUFU negative regulator of hedgehog signaling |
1552 |
0.33 |
chr5_139369045_139369211 | 3.57 |
Mir339 |
microRNA 339 |
617 |
0.59 |
chr2_32914450_32914614 | 3.56 |
Fam129b |
family with sequence similarity 129, member B |
179 |
0.91 |
chr5_120511752_120511921 | 3.55 |
Slc8b1 |
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 |
566 |
0.62 |
chr9_110350728_110350893 | 3.54 |
Scap |
SREBF chaperone |
6611 |
0.12 |
chr2_4902402_4902728 | 3.53 |
Phyh |
phytanoyl-CoA hydroxylase |
16454 |
0.13 |
chr18_32385962_32386113 | 3.53 |
A830052D11Rik |
RIKEN cDNA A830052D11 gene |
7759 |
0.19 |
chr18_61330113_61330460 | 3.53 |
Pde6a |
phosphodiesterase 6A, cGMP-specific, rod, alpha |
55263 |
0.08 |
chr7_27252126_27252620 | 3.51 |
Gm44641 |
predicted gene 44641 |
197 |
0.84 |
chr4_134067460_134067623 | 3.51 |
Crybg2 |
crystallin beta-gamma domain containing 2 |
911 |
0.42 |
chr1_66895610_66896410 | 3.51 |
Gm25832 |
predicted gene, 25832 |
29213 |
0.09 |
chr13_111871751_111871982 | 3.50 |
Gm15326 |
predicted gene 15326 |
726 |
0.58 |
chr1_74331641_74331792 | 3.49 |
Pnkd |
paroxysmal nonkinesiogenic dyskinesia |
894 |
0.38 |
chr2_157510022_157510334 | 3.49 |
Gm14279 |
predicted gene 14279 |
11850 |
0.13 |
chr1_171556458_171556620 | 3.47 |
Cd244a |
CD244 molecule A |
2654 |
0.14 |
chr9_105880827_105880978 | 3.47 |
Col6a5 |
collagen, type VI, alpha 5 |
904 |
0.62 |
chr8_119442578_119443025 | 3.47 |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
3918 |
0.18 |
chr1_136955166_136955491 | 3.46 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
1698 |
0.42 |
chr5_115528254_115528453 | 3.45 |
Pxn |
paxillin |
8048 |
0.09 |
chr5_125226466_125226633 | 3.42 |
Gm32585 |
predicted gene, 32585 |
46266 |
0.11 |
chr8_72503838_72503991 | 3.41 |
Gm17435 |
predicted gene, 17435 |
10970 |
0.08 |
chrX_17022295_17022446 | 3.41 |
Ndp |
Norrie disease (pseudoglioma) (human) |
110596 |
0.07 |
chr9_32519674_32519894 | 3.40 |
Gm37474 |
predicted gene, 37474 |
7174 |
0.12 |
chr4_41637175_41637517 | 3.39 |
Gm12406 |
predicted gene 12406 |
2032 |
0.17 |
chr6_142770028_142770219 | 3.38 |
Cmas |
cytidine monophospho-N-acetylneuraminic acid synthetase |
157 |
0.96 |
chr2_132638397_132638559 | 3.38 |
AU019990 |
expressed sequence AU019990 |
7403 |
0.13 |
chr4_105319067_105319262 | 3.37 |
Gm12722 |
predicted gene 12722 |
55782 |
0.16 |
chr3_85831893_85832058 | 3.36 |
Fam160a1 |
family with sequence similarity 160, member A1 |
14684 |
0.15 |
chr11_5782372_5782535 | 3.35 |
Dbnl |
drebrin-like |
6035 |
0.12 |
chr12_112586166_112586328 | 3.35 |
Inf2 |
inverted formin, FH2 and WH2 domain containing |
2537 |
0.22 |
chr10_41992198_41992354 | 3.35 |
Armc2 |
armadillo repeat containing 2 |
890 |
0.62 |
chr19_6035904_6036069 | 3.33 |
Gm19505 |
predicted gene, 19505 |
8121 |
0.05 |
chr19_41449775_41450079 | 3.32 |
Gm9788 |
predicted pseudogene 9788 |
9886 |
0.21 |
chr10_20632249_20632430 | 3.30 |
Gm17230 |
predicted gene 17230 |
6704 |
0.26 |
chr12_54313077_54313237 | 3.30 |
Gm47552 |
predicted gene, 47552 |
3858 |
0.22 |
chr18_56805077_56805233 | 3.29 |
Marchf3 |
membrane associated ring-CH-type finger 3 |
6864 |
0.22 |
chr8_122497127_122497278 | 3.28 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
1002 |
0.33 |
chr2_59884229_59884405 | 3.28 |
Wdsub1 |
WD repeat, SAM and U-box domain containing 1 |
1726 |
0.39 |
chr5_134170212_134170373 | 3.25 |
Rcc1l |
reculator of chromosome condensation 1 like |
917 |
0.46 |
chr2_128612368_128612671 | 3.25 |
Gm39929 |
predicted gene, 39929 |
2889 |
0.17 |
chr7_35146051_35146625 | 3.24 |
Gm35665 |
predicted gene, 35665 |
4889 |
0.12 |
chr18_20594228_20594534 | 3.24 |
Dsg2 |
desmoglein 2 |
36135 |
0.13 |
chr12_3859666_3859904 | 3.24 |
Dnmt3a |
DNA methyltransferase 3A |
1236 |
0.41 |
chr12_108046568_108046785 | 3.24 |
Bcl11b |
B cell leukemia/lymphoma 11B |
43074 |
0.17 |
chr2_153404099_153404282 | 3.23 |
Gm14472 |
predicted gene 14472 |
9659 |
0.16 |
chr15_4561546_4561984 | 3.23 |
C6 |
complement component 6 |
165410 |
0.03 |
chr4_86990221_86990372 | 3.23 |
Slc24a2 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
21377 |
0.23 |
chr1_165661837_165661988 | 3.22 |
Gm18407 |
predicted gene, 18407 |
17224 |
0.1 |
chr16_30475095_30475246 | 3.22 |
Gm49679 |
predicted gene, 49679 |
22582 |
0.18 |
chr9_119344192_119344359 | 3.21 |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
1502 |
0.25 |
chr2_167831188_167831379 | 3.21 |
1200007C13Rik |
RIKEN cDNA 1200007C13 gene |
2363 |
0.25 |
chr1_164212757_164212928 | 3.21 |
Slc19a2 |
solute carrier family 19 (thiamine transporter), member 2 |
36204 |
0.1 |
chrX_85784021_85784178 | 3.20 |
Gm14766 |
predicted gene 14766 |
6774 |
0.14 |
chr19_42602482_42602861 | 3.19 |
Loxl4 |
lysyl oxidase-like 4 |
650 |
0.71 |
chr17_42900854_42901005 | 3.18 |
Cd2ap |
CD2-associated protein |
24264 |
0.24 |
chr4_140620649_140620811 | 3.18 |
Arhgef10l |
Rho guanine nucleotide exchange factor (GEF) 10-like |
3665 |
0.23 |
chr17_13935466_13935617 | 3.18 |
Gm7168 |
predicted gene 7168 |
12832 |
0.16 |
chr4_154772160_154772331 | 3.18 |
Ttc34 |
tetratricopeptide repeat domain 34 |
65214 |
0.08 |
chr16_4896717_4896920 | 3.18 |
Mgrn1 |
mahogunin, ring finger 1 |
10432 |
0.11 |
chr5_146114373_146114524 | 3.17 |
Cyp3a59 |
cytochrome P450, family 3, subfamily a, polypeptide 59 |
35181 |
0.09 |
chr9_42441440_42441692 | 3.15 |
Gm44311 |
predicted gene, 44311 |
1286 |
0.41 |
chr9_54299505_54299794 | 3.15 |
Gldnos |
gliomedin, opposite strand |
1921 |
0.33 |
chr2_156585343_156585515 | 3.15 |
Gm14168 |
predicted gene 14168 |
13637 |
0.11 |
chr11_53757750_53757917 | 3.14 |
Mir7671 |
microRNA 7671 |
5821 |
0.11 |
chr11_77870675_77870826 | 3.12 |
Pipox |
pipecolic acid oxidase |
11936 |
0.14 |
chr5_33609349_33609519 | 3.12 |
Fam53a |
family with sequence similarity 53, member A |
19478 |
0.11 |
chr14_51104719_51104944 | 3.12 |
Rnase4 |
ribonuclease, RNase A family 4 |
8472 |
0.08 |
chr17_28178418_28178590 | 3.12 |
C230013L11Rik |
RIKEN cDNA C230013L11 gene |
822 |
0.37 |
chr7_137407509_137407671 | 3.11 |
9430038I01Rik |
RIKEN cDNA 9430038I01 gene |
3142 |
0.25 |
chr15_79234881_79235032 | 3.10 |
Pick1 |
protein interacting with C kinase 1 |
5254 |
0.1 |
chr10_78308725_78308893 | 3.10 |
AC160405.1 |
|
1190 |
0.23 |
chr18_46341760_46341934 | 3.09 |
4930415P13Rik |
RIKEN cDNA 4930415P13 gene |
1418 |
0.34 |
chr15_84973321_84973490 | 3.09 |
5031439G07Rik |
RIKEN cDNA 5031439G07 gene |
12422 |
0.11 |
chr15_83440834_83440989 | 3.08 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
8087 |
0.16 |
chr8_13075394_13076421 | 3.08 |
Gm17023 |
predicted gene 17023 |
170 |
0.9 |
chr5_33726324_33726568 | 3.07 |
Fgfr3 |
fibroblast growth factor receptor 3 |
2674 |
0.15 |
chr2_4721378_4721548 | 3.07 |
Bend7 |
BEN domain containing 7 |
3318 |
0.25 |
chr10_118765944_118766127 | 3.07 |
Gm4065 |
predicted gene 4065 |
39224 |
0.12 |
chr1_165625140_165625299 | 3.07 |
Mpzl1 |
myelin protein zero-like 1 |
8867 |
0.11 |
chr18_84376797_84376986 | 3.06 |
Gm37216 |
predicted gene, 37216 |
745 |
0.73 |
chr12_25265027_25265397 | 3.06 |
Gm19340 |
predicted gene, 19340 |
17383 |
0.18 |
chr16_95769487_95769687 | 3.04 |
Gm37259 |
predicted gene, 37259 |
9751 |
0.17 |
chr15_55878910_55879064 | 3.04 |
Sntb1 |
syntrophin, basic 1 |
27323 |
0.17 |
chr18_67201855_67202117 | 3.03 |
Chmp1b |
charged multivesicular body protein 1B |
3380 |
0.17 |
chr5_121616049_121616206 | 3.02 |
Acad12 |
acyl-Coenzyme A dehydrogenase family, member 12 |
2736 |
0.16 |
chr13_111937084_111937265 | 3.02 |
Gm9025 |
predicted gene 9025 |
52997 |
0.09 |
chr5_135054991_135055173 | 3.02 |
Gm25492 |
predicted gene, 25492 |
966 |
0.29 |
chr19_38134156_38134336 | 3.01 |
Pde6c |
phosphodiesterase 6C, cGMP specific, cone, alpha prime |
1300 |
0.38 |
chr3_98934072_98934263 | 3.01 |
5730437C11Rik |
RIKEN cDNA 5730437C11 gene |
7089 |
0.17 |
chr5_121657725_121657883 | 3.01 |
Acad10 |
acyl-Coenzyme A dehydrogenase family, member 10 |
2675 |
0.16 |
chr10_56444592_56444757 | 3.00 |
4930452L12Rik |
RIKEN cDNA 4930452L12 gene |
7071 |
0.2 |
chr13_37468607_37468985 | 3.00 |
Gm47731 |
predicted gene, 47731 |
3242 |
0.13 |
chr16_30954001_30954179 | 3.00 |
Gm46565 |
predicted gene, 46565 |
18461 |
0.15 |
chr5_137052026_137052177 | 3.00 |
Ap1s1 |
adaptor protein complex AP-1, sigma 1 |
5966 |
0.11 |
chr8_10910475_10910817 | 3.00 |
Gm2814 |
predicted gene 2814 |
10088 |
0.1 |
chr16_21646037_21646193 | 3.00 |
Vps8 |
VPS8 CORVET complex subunit |
18484 |
0.2 |
chr17_85928600_85928758 | 2.98 |
Gm30117 |
predicted gene, 30117 |
100 |
0.98 |
chr10_80256725_80256907 | 2.98 |
Gamt |
guanidinoacetate methyltransferase |
2473 |
0.11 |
chr6_125302611_125302786 | 2.97 |
Ltbr |
lymphotoxin B receptor |
6867 |
0.09 |
chr6_37347891_37348042 | 2.97 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
11431 |
0.26 |
chr4_43234117_43234284 | 2.96 |
Unc13b |
unc-13 homolog B |
393 |
0.84 |
chr6_147955095_147955255 | 2.95 |
Far2 |
fatty acyl CoA reductase 2 |
92084 |
0.07 |
chr2_97081866_97082017 | 2.95 |
4930445B16Rik |
RIKEN cDNA 4930445B16 gene |
1620 |
0.42 |
chr17_12673963_12674200 | 2.95 |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
1615 |
0.35 |
chr9_32648459_32648646 | 2.95 |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
12304 |
0.16 |
chr1_133190582_133190733 | 2.94 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
9336 |
0.18 |
chr8_114561262_114561425 | 2.94 |
Gm16116 |
predicted gene 16116 |
33557 |
0.18 |
chr3_68781530_68781884 | 2.94 |
Gm35584 |
predicted gene, 35584 |
20212 |
0.13 |
chr12_69451221_69451390 | 2.93 |
5830428M24Rik |
RIKEN cDNA 5830428M24 gene |
16087 |
0.15 |
chr11_105944433_105944606 | 2.93 |
Cyb561 |
cytochrome b-561 |
32 |
0.93 |
chr7_84457901_84458052 | 2.93 |
Gm45175 |
predicted gene 45175 |
13425 |
0.16 |
chr13_80895235_80895839 | 2.93 |
Arrdc3 |
arrestin domain containing 3 |
5019 |
0.18 |
chr7_144426711_144426872 | 2.92 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
8966 |
0.16 |
chr13_52941058_52941231 | 2.91 |
Auh |
AU RNA binding protein/enoyl-coenzyme A hydratase |
11463 |
0.19 |
chr5_36540802_36541170 | 2.91 |
Tbc1d14 |
TBC1 domain family, member 14 |
9384 |
0.16 |
chr8_115856297_115856482 | 2.91 |
Gm45733 |
predicted gene 45733 |
115682 |
0.06 |
chr7_31008253_31008404 | 2.91 |
Fam187b |
family with sequence similarity 187, member B |
26458 |
0.06 |
chr3_122313042_122313200 | 2.90 |
Bcar3 |
breast cancer anti-estrogen resistance 3 |
18985 |
0.1 |
chr5_108708507_108708693 | 2.90 |
Fgfrl1 |
fibroblast growth factor receptor-like 1 |
3526 |
0.15 |
chr11_121099879_121100030 | 2.89 |
Gm11791 |
predicted gene 11791 |
2747 |
0.12 |
chr1_190324672_190324829 | 2.89 |
Gm29678 |
predicted gene, 29678 |
78895 |
0.09 |
chr17_86447048_86447322 | 2.89 |
Prkce |
protein kinase C, epsilon |
43377 |
0.17 |
chr5_21384627_21384845 | 2.89 |
Fgl2 |
fibrinogen-like protein 2 |
12094 |
0.18 |
chr10_127888706_127889021 | 2.88 |
Rdh7 |
retinol dehydrogenase 7 |
46 |
0.95 |
chr2_169062295_169062478 | 2.88 |
Gm26469 |
predicted gene, 26469 |
1266 |
0.47 |
chr6_71836427_71836590 | 2.88 |
Gm44771 |
predicted gene 44771 |
4798 |
0.12 |
chr12_104414666_104414826 | 2.88 |
Gm24334 |
predicted gene, 24334 |
4654 |
0.15 |
chr5_113081179_113081330 | 2.87 |
Crybb3 |
crystallin, beta B3 |
144 |
0.92 |
chr8_128272968_128273154 | 2.87 |
Mir21c |
microRNA 21c |
5164 |
0.3 |
chr7_122118854_122119026 | 2.87 |
Palb2 |
partner and localizer of BRCA2 |
5505 |
0.1 |
chr4_57311880_57312039 | 2.86 |
Ptpn3 |
protein tyrosine phosphatase, non-receptor type 3 |
10122 |
0.18 |
chr1_180757970_180758155 | 2.86 |
Gm37768 |
predicted gene, 37768 |
2226 |
0.19 |
chr5_150954848_150955019 | 2.86 |
Kl |
klotho |
2229 |
0.34 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 10.6 | GO:0015817 | histidine transport(GO:0015817) |
2.3 | 9.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
2.0 | 6.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.7 | 5.2 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
1.7 | 8.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.6 | 4.7 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.5 | 4.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.4 | 7.2 | GO:0009115 | xanthine catabolic process(GO:0009115) |
1.4 | 4.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.3 | 6.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.3 | 3.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.3 | 3.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.3 | 1.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.2 | 3.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.2 | 3.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.2 | 3.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.2 | 3.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.2 | 4.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
1.2 | 3.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.2 | 9.2 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
1.1 | 5.7 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.1 | 5.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.1 | 7.9 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
1.1 | 4.5 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.1 | 3.4 | GO:0097195 | pilomotor reflex(GO:0097195) |
1.1 | 4.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.1 | 3.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.1 | 4.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.0 | 5.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.0 | 3.1 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
1.0 | 5.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.0 | 4.0 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.0 | 3.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.0 | 3.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.0 | 3.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.0 | 2.9 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.0 | 3.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.0 | 2.9 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.9 | 0.9 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.9 | 3.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.9 | 3.7 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.9 | 7.3 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.9 | 2.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.9 | 2.7 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.9 | 2.7 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.9 | 1.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.9 | 4.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.9 | 7.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.9 | 3.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.9 | 2.6 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.9 | 6.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.9 | 0.9 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.8 | 3.4 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.8 | 2.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.8 | 2.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.8 | 4.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.8 | 2.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.8 | 1.6 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.8 | 2.5 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.8 | 3.2 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.8 | 3.2 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.8 | 2.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.8 | 6.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.8 | 0.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.8 | 2.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.8 | 3.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.8 | 2.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.8 | 2.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 2.3 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.8 | 2.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.8 | 2.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.8 | 4.6 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.8 | 2.3 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.7 | 3.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.7 | 1.5 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.7 | 4.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.7 | 2.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 2.9 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.7 | 3.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.7 | 3.6 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.7 | 0.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.7 | 2.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.7 | 2.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 2.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.7 | 2.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.7 | 1.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.7 | 0.7 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.7 | 4.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.7 | 2.8 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.7 | 2.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.7 | 1.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.7 | 0.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.7 | 2.8 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.7 | 0.7 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
0.7 | 2.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.7 | 1.4 | GO:1902896 | terminal web assembly(GO:1902896) |
0.7 | 0.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.7 | 2.8 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.7 | 2.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.7 | 4.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.7 | 2.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.7 | 1.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.7 | 2.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.7 | 1.4 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.7 | 1.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.7 | 2.0 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.7 | 1.3 | GO:0032345 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.7 | 1.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.7 | 2.6 | GO:0001798 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.7 | 2.0 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.7 | 3.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.7 | 0.7 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.7 | 2.0 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.7 | 0.7 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.6 | 4.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.6 | 0.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.6 | 1.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.6 | 1.9 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.6 | 1.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.6 | 1.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 1.9 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.6 | 3.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.6 | 2.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 0.6 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.6 | 0.6 | GO:0009750 | response to fructose(GO:0009750) |
0.6 | 7.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.6 | 5.6 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.6 | 1.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.6 | 1.9 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.6 | 1.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.6 | 1.2 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.6 | 1.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.6 | 1.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.6 | 1.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.6 | 2.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.6 | 1.8 | GO:0017085 | response to insecticide(GO:0017085) |
0.6 | 1.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.6 | 1.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.6 | 1.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.6 | 2.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.6 | 1.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.6 | 1.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.6 | 1.2 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.6 | 1.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.6 | 1.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 0.6 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.6 | 0.6 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.6 | 1.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 1.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.6 | 1.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.6 | 4.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.6 | 4.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.6 | 12.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.6 | 5.8 | GO:0046697 | decidualization(GO:0046697) |
0.6 | 1.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.6 | 0.6 | GO:0018158 | protein oxidation(GO:0018158) |
0.6 | 4.0 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.6 | 1.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.6 | 4.0 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.6 | 1.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.6 | 1.7 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.6 | 1.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.6 | 1.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.6 | 2.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.6 | 0.6 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.6 | 0.6 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.6 | 1.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.6 | 6.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.6 | 1.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 0.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.6 | 0.6 | GO:0010226 | response to lithium ion(GO:0010226) |
0.6 | 0.6 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.5 | 2.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 0.5 | GO:0006848 | pyruvate transport(GO:0006848) |
0.5 | 1.6 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.5 | 2.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 1.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.5 | 7.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.5 | 1.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.5 | 1.6 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.5 | 1.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.5 | 1.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 1.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.5 | 1.1 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.5 | 4.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.5 | 1.6 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.5 | 0.5 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.5 | 3.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.5 | 2.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.5 | 3.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.5 | 1.6 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.5 | 1.6 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.5 | 0.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.5 | 2.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.5 | 1.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 3.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.5 | 1.0 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.5 | 1.6 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.5 | 2.1 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 1.5 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 1.5 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.5 | 2.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 1.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.5 | 1.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.5 | 2.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.5 | 1.5 | GO:2000855 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.5 | 2.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.5 | 6.0 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.5 | 3.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.5 | 1.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.5 | 1.5 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.5 | 2.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 1.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.5 | 3.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.5 | 0.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.5 | 1.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.5 | 1.5 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.5 | 2.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 1.0 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.5 | 2.9 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.5 | 2.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 1.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.5 | 1.5 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 1.0 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.5 | 1.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 2.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 0.5 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.5 | 1.4 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.5 | 1.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.5 | 1.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.5 | 0.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.5 | 1.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 1.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.5 | 5.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.5 | 1.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.5 | 0.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.5 | 2.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.5 | 1.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.5 | 0.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.5 | 0.9 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.5 | 2.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.5 | 1.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.5 | 0.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.5 | 1.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 2.3 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.5 | 2.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.5 | 1.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 4.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 4.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.5 | 0.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 1.8 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.5 | 1.8 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.5 | 0.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.5 | 0.5 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.5 | 0.9 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.5 | 0.5 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.5 | 0.9 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.4 | 0.4 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.4 | 2.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.4 | 1.8 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.4 | 0.9 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.4 | 1.3 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.4 | 2.7 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.4 | 0.9 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 1.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 1.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.4 | 0.9 | GO:0072262 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.4 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 0.9 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.4 | 1.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.4 | 1.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.4 | 2.2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.4 | 0.4 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.4 | 2.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 0.9 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.4 | 1.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 0.9 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.4 | 1.7 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.4 | 0.4 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.4 | 1.7 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.4 | 1.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 3.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 1.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 2.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.4 | 0.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 0.9 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.4 | 4.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 1.3 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.4 | 3.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 0.9 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.4 | 0.4 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.4 | 0.9 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 2.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 1.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 0.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.4 | 1.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 0.4 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.4 | 0.8 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 1.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 0.8 | GO:0070268 | cornification(GO:0070268) |
0.4 | 1.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 1.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.4 | 0.4 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 1.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 3.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 1.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 0.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 1.2 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.4 | 2.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 1.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 2.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 1.6 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 0.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.4 | 1.6 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 1.6 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.4 | 1.6 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.4 | 2.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 0.4 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.4 | 1.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 4.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 2.0 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 4.0 | GO:0018904 | ether metabolic process(GO:0018904) |
0.4 | 0.8 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.4 | 1.6 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 1.6 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.4 | 0.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 1.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 0.8 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 2.4 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.4 | 0.8 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 0.4 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.4 | 0.8 | GO:0001555 | oocyte growth(GO:0001555) |
0.4 | 0.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.4 | 2.8 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.4 | 0.4 | GO:0010159 | specification of organ position(GO:0010159) |
0.4 | 1.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 1.6 | GO:0018377 | protein myristoylation(GO:0018377) |
0.4 | 4.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 3.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 2.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.4 | 1.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.4 | 1.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.4 | 2.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 0.4 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.4 | 0.8 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.4 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 2.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 1.5 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 2.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 1.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.4 | 2.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 1.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.4 | 1.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 0.8 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.4 | 0.8 | GO:0033058 | directional locomotion(GO:0033058) |
0.4 | 2.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 0.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.4 | 0.4 | GO:0015840 | urea transport(GO:0015840) |
0.4 | 1.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.4 | 1.9 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.4 | 0.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.4 | 3.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 2.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 1.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.4 | 1.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 0.4 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.4 | 1.1 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.4 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.4 | 0.7 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 2.6 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.4 | 3.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.4 | 0.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.4 | 3.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.4 | 1.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.4 | 2.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.4 | 0.7 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.4 | 1.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 1.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.4 | 1.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 0.4 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.4 | 1.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.4 | 1.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.4 | 0.4 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.4 | 0.7 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.4 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 1.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.4 | 2.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 1.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.4 | 1.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 1.8 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.4 | 1.1 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.4 | 1.1 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.4 | 3.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.4 | 0.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.4 | 0.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 0.7 | GO:0031639 | plasminogen activation(GO:0031639) |
0.4 | 0.4 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.4 | 1.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.4 | 1.4 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.4 | 1.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 1.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.4 | 1.8 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.3 | 0.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 1.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 0.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 0.3 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.3 | 0.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 0.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 2.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 0.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.3 | 3.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 0.7 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 1.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 1.0 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.3 | 0.7 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 0.3 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.3 | 7.8 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.3 | 1.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.3 | 0.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.3 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 1.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 0.7 | GO:0002337 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.3 | 0.7 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.3 | 3.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 0.3 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.3 | 1.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.3 | 0.7 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 0.3 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.3 | 0.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 2.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 1.0 | GO:0007567 | parturition(GO:0007567) |
0.3 | 1.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 1.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 1.6 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.3 | 1.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 1.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 0.7 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.3 | 0.3 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.3 | 1.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 0.7 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.3 | 1.0 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 3.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 0.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 1.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 0.3 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.3 | 0.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.3 | 1.6 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.3 | 0.3 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 1.0 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 0.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 1.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.3 | 1.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 8.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 2.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 2.8 | GO:0008272 | sulfate transport(GO:0008272) |
0.3 | 0.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.3 | 0.9 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 0.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 2.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 2.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 0.9 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 1.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 0.9 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.3 | 0.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 1.9 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.3 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 1.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 0.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 2.5 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.3 | 3.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 1.2 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 0.6 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 0.6 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 0.6 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.3 | 0.3 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.3 | 2.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 1.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 1.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 1.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 1.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.3 | 0.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 1.2 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.3 | 1.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 0.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 1.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 3.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 0.6 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 0.9 | GO:1903361 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 0.9 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 0.9 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.3 | 2.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 2.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.3 | 0.9 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.3 | 0.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 2.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 3.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 0.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 1.7 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.3 | 0.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 5.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.3 | 0.3 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.3 | 1.7 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 0.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 0.3 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.3 | 0.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 1.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 1.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 6.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 1.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 0.3 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.3 | 1.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 1.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 1.1 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.3 | 1.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.3 | 0.8 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.3 | 0.8 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 6.9 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 0.6 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.3 | 0.3 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.3 | 2.2 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.3 | 1.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 1.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 2.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 0.3 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 0.3 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.3 | 1.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.3 | 0.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 1.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 1.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.3 | 1.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 0.8 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.3 | 0.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 1.6 | GO:0030220 | platelet formation(GO:0030220) |
0.3 | 0.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 0.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 0.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.3 | 1.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 1.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.3 | 0.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 0.3 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.3 | 0.5 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.5 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.3 | 2.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.3 | 1.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 0.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.3 | 1.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 0.5 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 1.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 0.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.3 | 1.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.3 | 2.9 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.3 | 2.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.3 | 8.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.3 | 0.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.3 | 1.8 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 0.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 1.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.3 | GO:0052433 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
0.3 | 0.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.3 | 1.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 1.3 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.3 | 0.5 | GO:0051794 | regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) |
0.3 | 0.8 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.3 | 0.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 1.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 0.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 0.8 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 1.0 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.3 | 1.3 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.3 | 0.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 2.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.3 | 1.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 2.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 0.3 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.3 | 0.8 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 1.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 1.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 1.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 0.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.7 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.2 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 2.2 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.2 | 0.7 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.2 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.2 | 2.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 1.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.2 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.2 | 1.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 1.0 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.2 | 1.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.7 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 0.5 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 0.5 | GO:2000136 | regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
0.2 | 1.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.5 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 1.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 0.7 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.2 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.2 | 0.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 2.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 1.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 0.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.2 | 1.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 1.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.2 | 0.5 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.2 | 3.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.7 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.9 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 2.4 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.7 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.2 | 0.7 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.7 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.2 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.9 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 0.2 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.5 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 1.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 1.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.2 | 1.4 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 1.8 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 1.4 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.2 | 0.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.2 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.2 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.5 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 1.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.5 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 0.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.9 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 0.4 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 1.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 0.9 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 2.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.4 | GO:0072017 | distal tubule development(GO:0072017) |
0.2 | 0.9 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 0.7 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 1.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.2 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 2.9 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 0.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 15.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 0.4 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.2 | 1.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 1.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.6 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.2 | 0.4 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 0.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 3.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 1.7 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.2 | 1.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.2 | GO:0046959 | nonassociative learning(GO:0046958) habituation(GO:0046959) |
0.2 | 0.2 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.6 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.2 | 0.2 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 0.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 1.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 2.8 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.2 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 1.5 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.2 | 3.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.4 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.2 | 0.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 2.7 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 2.1 | GO:0030449 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.2 | 0.6 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 2.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 2.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 1.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.8 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 2.9 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 1.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 1.4 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.2 | 1.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.6 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 1.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 0.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 0.8 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.2 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.4 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.2 | 1.0 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.2 | 0.2 | GO:0003174 | mitral valve development(GO:0003174) |
0.2 | 1.0 | GO:0033273 | response to vitamin(GO:0033273) |
0.2 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 0.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 0.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 0.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.2 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.2 | 0.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.2 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.2 | 1.6 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 0.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 1.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 1.6 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.4 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.2 | 2.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 1.4 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.2 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 1.4 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.2 | 2.0 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 0.8 | GO:0070723 | response to cholesterol(GO:0070723) |
0.2 | 0.6 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
0.2 | 0.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 1.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.8 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.6 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.2 | 0.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.2 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 1.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.4 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.2 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.4 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 2.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 2.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 1.0 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 1.0 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 5.9 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 0.8 | GO:0014047 | glutamate secretion(GO:0014047) |
0.2 | 0.9 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.2 | 0.2 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.2 | 0.2 | GO:0070293 | renal absorption(GO:0070293) |
0.2 | 0.4 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.6 | GO:0046070 | dGTP catabolic process(GO:0006203) dGTP metabolic process(GO:0046070) |
0.2 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 0.2 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.2 | 0.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.2 | 0.4 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 1.5 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.2 | 1.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.6 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 1.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 1.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 1.8 | GO:0070633 | transepithelial transport(GO:0070633) |
0.2 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.4 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.2 | 1.3 | GO:0051383 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.2 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.5 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.2 | 0.4 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.2 | 0.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 2.2 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.2 | 2.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 2.3 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.2 | 0.4 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 3.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.2 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.2 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.9 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 2.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.4 | GO:0010712 | regulation of collagen metabolic process(GO:0010712) |
0.2 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 1.2 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 1.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.2 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 0.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 0.2 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 5.2 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 1.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 2.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.2 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.2 | 0.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 2.6 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.7 | GO:0009838 | abscission(GO:0009838) |
0.2 | 0.5 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.2 | 1.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.7 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.2 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.2 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 1.5 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.2 | 0.8 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.2 | 0.3 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.2 | 0.2 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) positive regulation of T cell tolerance induction(GO:0002666) |
0.2 | 0.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) negative regulation of translational elongation(GO:0045900) |
0.2 | 1.5 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 0.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.2 | 0.2 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.2 | 1.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 1.3 | GO:0046348 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) amino sugar catabolic process(GO:0046348) |
0.2 | 1.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 1.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.2 | 1.5 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.2 | 0.5 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.2 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 1.0 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 0.3 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.2 | 0.6 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.2 | 0.2 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 1.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.5 | GO:0043570 | meiotic mismatch repair(GO:0000710) maintenance of DNA repeat elements(GO:0043570) |
0.2 | 0.5 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 4.7 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.2 | 0.2 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.2 | 0.5 | GO:0034184 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 2.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 3.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.5 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 1.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 1.8 | GO:0044062 | regulation of excretion(GO:0044062) |
0.2 | 1.1 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.2 | 0.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.3 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 0.3 | GO:0009651 | response to salt stress(GO:0009651) |
0.2 | 0.6 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.2 | 0.2 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 0.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 0.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 2.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.4 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 1.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 3.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 2.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.3 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.1 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.9 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 1.0 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 1.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.4 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 1.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.3 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.1 | 0.7 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.1 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 1.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.7 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.4 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 1.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 4.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 1.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 1.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 2.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.1 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.7 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.7 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.3 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 2.6 | GO:0070613 | regulation of protein processing(GO:0070613) |
0.1 | 1.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 1.1 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
0.1 | 0.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 1.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 2.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 1.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 1.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.6 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.6 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.3 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.1 | 1.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 1.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.9 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.1 | 2.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 2.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 2.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.4 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 0.6 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.6 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.8 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.1 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.1 | 0.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 1.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 1.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.2 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.7 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 2.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.2 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.1 | 0.3 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 0.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 1.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 7.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 2.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.5 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.3 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.3 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.6 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 1.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 9.9 | GO:0007601 | visual perception(GO:0007601) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 1.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 1.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 1.3 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.1 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) |
0.1 | 0.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.4 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 1.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 1.2 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 3.3 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.7 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.1 | 1.6 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.1 | GO:0033026 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.5 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 1.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 5.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.3 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 1.1 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.1 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.9 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.1 | 2.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.6 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.3 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.1 | 0.5 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.2 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
0.1 | 0.1 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 1.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.1 | GO:1903317 | regulation of protein maturation(GO:1903317) |
0.1 | 0.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.1 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 1.3 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 1.9 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0046864 | retinol transport(GO:0034633) vitamin transmembrane transport(GO:0035461) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.1 | GO:0044851 | hair cycle phase(GO:0044851) |
0.1 | 0.3 | GO:0071371 | response to gonadotropin(GO:0034698) cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 1.3 | GO:0002209 | behavioral defense response(GO:0002209) |
0.1 | 2.8 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.4 | GO:0007595 | lactation(GO:0007595) |
0.1 | 0.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.1 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.1 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.1 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.1 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.8 | GO:0001707 | mesoderm formation(GO:0001707) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
0.1 | 1.0 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.1 | 0.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 2.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.9 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 1.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.2 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.5 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.5 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.4 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.2 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.9 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 1.1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 1.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.1 | GO:1901018 | positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.3 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 0.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 2.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.1 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.1 | 0.1 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
0.1 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.1 | GO:2000542 | negative regulation of endodermal cell differentiation(GO:1903225) negative regulation of gastrulation(GO:2000542) |
0.1 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 2.4 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 1.0 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.1 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 0.1 | GO:0060572 | morphogenesis of an epithelial bud(GO:0060572) |
0.1 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.8 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.1 | 0.1 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.1 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 1.3 | GO:0022405 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.4 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 1.1 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 0.5 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.1 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.4 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.7 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) protein localization to axon(GO:0099612) |
0.1 | 0.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.3 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.1 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.6 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.1 | 0.3 | GO:0034397 | telomere localization(GO:0034397) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.8 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.4 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.3 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 1.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.1 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.3 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.1 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 2.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.8 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.2 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.0 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.3 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.5 | GO:0002275 | myeloid cell activation involved in immune response(GO:0002275) |
0.0 | 0.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 1.8 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.0 | 0.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 1.7 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.0 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.0 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.7 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 1.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.2 | GO:0060343 | trabecula formation(GO:0060343) |
0.0 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.2 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.0 | 0.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.0 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.0 | 0.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.1 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.4 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.2 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.2 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 2.6 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.0 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.0 | GO:0061440 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) |
0.0 | 0.1 | GO:0042148 | strand invasion(GO:0042148) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) negative regulation of glomerular filtration(GO:0003105) |
0.0 | 0.2 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.4 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.0 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.0 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.0 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.0 | 0.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.0 | 0.0 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.0 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.0 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.0 | 0.2 | GO:0051647 | nucleus localization(GO:0051647) |
0.0 | 0.0 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.5 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.0 | 0.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.0 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.0 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.0 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.6 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.0 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.6 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.0 | 0.0 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.0 | GO:0002524 | hypersensitivity(GO:0002524) |
0.0 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.5 | 10.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.5 | 4.4 | GO:0031523 | Myb complex(GO:0031523) |
1.3 | 5.1 | GO:1990246 | uniplex complex(GO:1990246) |
1.2 | 3.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.1 | 3.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.1 | 1.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.0 | 3.0 | GO:0097443 | sorting endosome(GO:0097443) |
1.0 | 2.9 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.0 | 2.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.9 | 5.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.9 | 0.9 | GO:0032010 | phagolysosome(GO:0032010) |
0.9 | 5.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.9 | 3.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 4.6 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.7 | 4.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.7 | 2.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 2.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.7 | 2.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 2.0 | GO:0005767 | secondary lysosome(GO:0005767) |
0.7 | 0.7 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.6 | 1.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 1.9 | GO:0035838 | growing cell tip(GO:0035838) |
0.6 | 1.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.6 | 2.3 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.6 | 2.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 12.1 | GO:0030057 | desmosome(GO:0030057) |
0.6 | 5.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.6 | 1.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 3.3 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 2.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.5 | 3.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 2.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 6.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 3.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.5 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 1.5 | GO:1990462 | omegasome(GO:1990462) |
0.5 | 3.5 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 1.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.5 | 2.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.5 | 1.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 3.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 1.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.5 | 8.0 | GO:0001741 | XY body(GO:0001741) |
0.5 | 7.4 | GO:0000145 | exocyst(GO:0000145) |
0.5 | 0.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 4.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.4 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 1.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 1.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 1.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 2.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 3.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 1.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 3.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 0.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 7.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 1.6 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 1.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 2.4 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.4 | 3.1 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.4 | 1.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 2.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 2.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 1.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 1.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.4 | 1.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 1.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.4 | 7.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.4 | 2.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 1.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 1.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 2.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 1.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.3 | 1.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 0.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.3 | 2.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 2.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 1.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 0.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 0.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 2.2 | GO:0000801 | central element(GO:0000801) |
0.3 | 0.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 5.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 6.1 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 2.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 2.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 2.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 0.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 15.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 3.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 2.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 2.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 0.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 0.3 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.3 | 1.5 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 2.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 0.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 0.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 1.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 2.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 0.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 0.9 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 5.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 1.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 0.6 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 7.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 3.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 3.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 1.5 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 0.5 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 1.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 0.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 1.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 1.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 3.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 2.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 1.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 1.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.2 | 0.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 1.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 1.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 2.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.7 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 1.4 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.7 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 1.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 4.5 | GO:0097346 | INO80-type complex(GO:0097346) |
0.2 | 0.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 2.5 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 0.9 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 4.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 1.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 7.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 1.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 3.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 1.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 1.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 2.3 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 1.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 1.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 2.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 0.8 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 1.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.0 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 1.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.4 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 0.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 7.7 | GO:0043235 | receptor complex(GO:0043235) |
0.2 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 0.9 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.2 | GO:0098552 | side of membrane(GO:0098552) |
0.2 | 4.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 3.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 2.5 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 1.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 2.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 1.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 2.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 2.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 7.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.7 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 2.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 1.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 1.2 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 5.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 7.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 1.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 1.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.2 | 3.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 1.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 1.7 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 22.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 5.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 3.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 12.3 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.3 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 1.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.6 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 1.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 2.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 1.9 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 5.1 | GO:0005844 | polysome(GO:0005844) |
0.1 | 15.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 2.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 1.1 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 6.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.1 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 18.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 17.8 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.1 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.4 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 4.8 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 1.9 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 2.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 3.9 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 1.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 2.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 3.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 8.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 1.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 4.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 1.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.3 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 2.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 2.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 78.1 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 1.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 5.3 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.7 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 2.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.3 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.2 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 11.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.0 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 8.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.9 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 0.1 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 2.7 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 2.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 5.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 1.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.6 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 5.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 1.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 11.0 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 1.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.6 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 4.0 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 6.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 30.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 9.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 2.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 1.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.4 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 68.2 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.8 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
3.2 | 9.7 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.8 | 5.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.8 | 14.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.5 | 4.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.4 | 4.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.4 | 7.2 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
1.3 | 3.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.2 | 3.5 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.1 | 3.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.1 | 3.3 | GO:0004103 | choline kinase activity(GO:0004103) |
1.1 | 5.3 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
1.0 | 4.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.0 | 4.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.0 | 3.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.0 | 3.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.0 | 11.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.9 | 5.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.9 | 2.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.9 | 4.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.9 | 2.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.9 | 3.6 | GO:0045340 | mercury ion binding(GO:0045340) |
0.9 | 2.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.9 | 2.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.9 | 6.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.9 | 3.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.9 | 4.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.9 | 6.1 | GO:0034791 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.8 | 3.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.8 | 2.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.8 | 2.5 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.8 | 3.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.8 | 2.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 4.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.8 | 2.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.8 | 4.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.8 | 3.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.8 | 4.8 | GO:0043426 | MRF binding(GO:0043426) |
0.8 | 4.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.8 | 4.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 2.3 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.8 | 3.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.8 | 2.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.8 | 2.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 2.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.7 | 3.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 2.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 5.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 0.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.7 | 2.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.7 | 1.4 | GO:0015116 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.7 | 2.9 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.7 | 2.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 2.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.7 | 6.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.7 | 2.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.7 | 2.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.7 | 2.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.7 | 2.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 2.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.7 | 2.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 2.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.7 | 2.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.7 | 0.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.6 | 3.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 2.6 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.6 | 1.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.6 | 5.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.6 | 1.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 1.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.6 | 1.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.6 | 1.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.6 | 4.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.6 | 1.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.6 | 6.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.6 | 0.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 2.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.6 | 1.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.6 | 2.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.6 | 5.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.6 | 0.6 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.6 | 2.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.5 | 2.7 | GO:0070061 | fructose binding(GO:0070061) |
0.5 | 2.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 1.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 4.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.5 | 1.6 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.5 | 2.1 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.5 | 1.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 3.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.5 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 26.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 1.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 2.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.5 | 2.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.5 | 2.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.5 | 2.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.5 | 1.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.5 | 5.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 1.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.5 | 1.9 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.5 | 1.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 1.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 2.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 7.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.5 | 2.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.5 | 1.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.5 | 1.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.5 | 7.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 2.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 1.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.5 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.5 | 1.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 1.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 1.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.5 | 1.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 3.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.5 | 1.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.5 | 2.7 | GO:0034901 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.5 | 0.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.5 | 1.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 3.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 5.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 2.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 1.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.4 | 1.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 1.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 2.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 0.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 2.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 1.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.4 | 2.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.4 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 2.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 2.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 3.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 1.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 2.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 3.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 1.3 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.4 | 4.2 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.4 | 9.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.4 | 1.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 4.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 5.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.4 | 1.6 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 1.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 2.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 1.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.4 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 1.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.4 | 0.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 4.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 1.2 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 0.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 1.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 1.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 1.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 1.9 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.4 | 0.4 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.4 | 2.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 1.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 5.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 1.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 0.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.4 | 1.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 1.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.4 | 2.9 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 0.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.4 | 1.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 7.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 1.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 0.7 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 7.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 2.0 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 1.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 1.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 2.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 1.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 1.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 1.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 1.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 1.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 5.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 1.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.9 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 1.3 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 2.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 2.5 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 1.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.3 | 2.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.9 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.3 | 0.3 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 3.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 8.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 3.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 5.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 0.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.3 | 2.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.3 | 3.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 5.0 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 1.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 0.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 1.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 1.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 2.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 0.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 2.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 1.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 3.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 4.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 1.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 2.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 6.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 0.3 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.3 | 0.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 16.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 3.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 1.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 5.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 1.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 0.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 0.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 3.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 2.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.3 | 1.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 5.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 1.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 1.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 1.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 1.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.3 | 1.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 1.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.3 | 2.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 1.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 0.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 0.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 0.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 5.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 1.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 0.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 1.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 2.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 2.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 3.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 1.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 1.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 5.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 1.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 2.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 7.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 0.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.3 | 1.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 7.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 2.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.3 | 0.3 | GO:0008193 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 1.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 2.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 1.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 4.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 1.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 0.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 2.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.7 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 2.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 1.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 1.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 1.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 2.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.2 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.7 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 3.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.7 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 1.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.5 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 2.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 2.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.2 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.2 | 4.5 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.2 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 4.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 2.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 0.9 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 1.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 0.2 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.2 | 3.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 1.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.6 | GO:0015265 | urea channel activity(GO:0015265) |
0.2 | 1.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 2.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 2.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 1.0 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.2 | 2.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 1.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 3.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 1.0 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.2 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 1.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 2.8 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.2 | 1.0 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 4.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 2.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 7.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 0.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 2.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.2 | 1.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 3.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 8.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 2.8 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 0.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 3.4 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 5.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 6.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 2.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 2.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 1.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 1.8 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 1.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 1.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 1.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 0.5 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 0.5 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 1.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.9 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.2 | 1.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 2.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 5.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 1.7 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 2.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.9 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 5.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 1.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 1.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 5.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 4.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 2.8 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 2.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 1.3 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.2 | 1.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.5 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 5.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 0.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.2 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.2 | 2.2 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 0.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 0.6 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.9 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 0.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 2.1 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 1.2 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 0.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.9 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 3.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.6 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 1.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.4 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.1 | 5.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 1.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 1.0 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.1 | 0.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.4 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 3.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 1.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.8 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 1.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 4.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 13.5 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 7.9 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 24.8 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 6.4 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.6 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 2.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 2.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 1.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.8 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 1.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 12.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 2.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.4 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 1.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.4 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 1.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 3.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.5 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 1.0 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 1.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 19.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.4 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 1.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.8 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 1.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.3 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 2.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 2.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 1.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.6 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 1.5 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.4 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 1.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 26.3 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 2.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 1.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 2.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 4.1 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.1 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 1.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.1 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 3.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.0 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 1.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 1.1 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 3.6 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 2.4 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.9 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 7.4 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 3.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 1.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.4 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 2.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.0 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.0 | 1.3 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 1.7 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 1.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.2 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.0 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.3 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 1.2 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.9 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.0 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 1.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 1.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0032138 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.0 | 0.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.9 | GO:0005550 | pheromone binding(GO:0005550) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 1.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 21.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.7 | 1.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.7 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 4.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 1.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 7.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 20.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.4 | 5.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 10.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 21.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 7.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.4 | 5.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 11.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 9.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 2.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 11.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 5.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 4.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 11.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 1.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 6.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 2.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 1.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 1.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 3.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 0.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 0.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 3.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 3.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 9.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 5.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 4.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 8.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 5.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 1.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 3.1 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 1.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 9.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 3.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 0.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 3.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 2.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 2.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 5.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 3.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 2.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 3.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 1.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 4.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 4.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 5.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 8.7 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 3.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 3.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 7.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 0.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 2.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 3.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 2.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 1.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 1.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 5.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 29.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 3.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.8 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 8.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 5.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 13.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 3.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.6 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 1.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.3 | 1.3 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
1.1 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.1 | 1.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
1.1 | 1.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
1.0 | 14.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.9 | 2.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.9 | 11.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.8 | 8.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.8 | 0.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.8 | 7.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.7 | 9.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.7 | 8.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.7 | 1.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.7 | 0.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.6 | 17.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 7.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 2.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.5 | 10.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.5 | 2.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.4 | 3.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 3.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 8.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.4 | 7.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 8.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 9.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 5.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.4 | 4.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 3.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 5.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.4 | 8.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 17.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 5.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 4.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 3.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 5.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 0.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 6.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 1.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 2.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 3.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 6.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 0.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 5.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 2.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 7.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 5.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 2.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 2.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 3.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 4.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 1.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 2.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 1.4 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.3 | 7.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 3.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 3.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 4.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.3 | 2.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 7.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 1.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 2.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 0.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.3 | 3.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 0.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 4.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 2.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 4.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 2.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 2.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 4.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 3.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 4.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 2.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 1.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 0.9 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 1.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 1.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 2.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 0.2 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.2 | 2.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 2.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 1.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 3.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 1.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 3.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 6.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 0.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 11.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 3.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 5.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 8.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 18.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 4.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 2.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 1.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 0.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 2.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 3.6 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.2 | 1.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 1.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 4.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 0.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 0.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 3.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 3.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 4.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 2.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 4.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 2.6 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 4.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 1.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 2.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 4.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 3.5 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 0.3 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.1 | 0.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 1.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 2.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.7 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 2.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 3.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 2.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 3.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 3.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 4.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 7.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.2 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.1 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.8 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 2.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.0 | 0.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.0 | 0.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 6.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 3.9 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 1.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 2.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.0 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |